Calpain mediates calcium-induced activation of the erk1,2 MAPK pathway and cytoskeletal phosphorylation in neurons: relevance to Alzheimer's disease

The American Journal of Pathology
VeerannaRalph A Nixon

Abstract

Aberrant phosphorylation of the neuronal cytoskeleton is an early pathological event in Alzheimer's disease (AD), but the underlying mechanisms are unclear. Here, we demonstrate in the brains of AD patients that neurofilament hyperphosphorylation in neocortical pyramidal neurons is accompanied by activation of both Erk1,2 and calpain. Using immunochemistry, Western blot analysis, and kinase activity measurements, we show in primary hippocampal and cerebellar granule (CG) neurons that calcium influx activates calpain and Erk1,2 and increases neurofilament phosphorylation on carboxy terminal polypeptide sites known to be modulated by Erk1,2 and to be altered in AD. Blocking Erk1,2 activity either with antisense oligonucleotides to Erk1,2 mRNA sequences or by specifically inhibiting its upstream activating kinase MEK1,2 markedly reduced neurofilament phosphorylation. Calpeptin, a cell-permeable calpain inhibitor, blocked both Erk1,2 activation and neurofilament hyperphosphorylation at concentrations that inhibit calpain-mediated cleavage of brain spectrin. By contrast, inhibiting Erk1,2 with U-0126, a specific inhibitor of Mek1,2, had no appreciable effect on ionomycin-induced calpain activation. These findings demonstrate that, u...Continue Reading

References

Nov 1, 1991·Trends in Neurosciences·R A Nixon, R K Sihag
Jan 1, 1991·Acta Neuropathologica·H Braak, E Braak
Mar 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·V M LeeR A Lazzarini
Aug 11, 1989·Nucleic Acids Research·G Lacoste-RoyalD Gauvreau
Jun 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·N H SternbergerJ Ulrich
Nov 24, 1995·Science·Z XiaM E Greenberg
Oct 1, 1994·Journal of Neuroscience Research·G MorfiniA Cáceres
Jul 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·K T ShettyH C Pant
Apr 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·K SaitoR A Nixon
Oct 1, 1995·Journal of Neurotrauma·I Mocchetti, J R Wrathall
Apr 1, 1997·Current Opinion in Cell Biology·M J Robinson, M H Cobb
Oct 23, 1997·Science·J H Morrison, P R Hof
Dec 12, 1997·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·G V Johnson, R P Guttmann
Feb 17, 1998·Trends in Neurosciences·A Verkhratsky, E C Toescu
Sep 30, 1998·Proceedings of the National Academy of Sciences of the United States of America·B MurrayE J Furshpan
Apr 9, 1999·Journal of Neurology·S Lovestone
Jun 1, 1999·Journal of the International Neuropsychological Society : JINS·M J DixonM Arguin
Oct 6, 1999·Current Opinion in Neurobiology·J P Julien
May 29, 2000·The Journal of Biological Chemistry·S LankiewiczJ H Prehn
Aug 12, 2000·Platelets·S M SchoenwaelderS P Jackson
Oct 19, 2001·Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics·S KosakaH Mori
Feb 21, 2002·Trends in Cell Biology·Angela GladingAlan Wells
Mar 15, 2002·Cell·Tudor MoldoveanuPeter L Davies
May 10, 2002·The Journal of Biological Chemistry·Shirley Gil-ParradoWerner Machleidt
Mar 26, 2003·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Ammar Al-Chalabi, Christopher C J Miller

❮ Previous
Next ❯

Citations

Mar 7, 2012·Cell and Tissue Research·Paul LingorMathias Bähr
Aug 8, 2008·Molecular Neurobiology·P S VoslerJ Chen
May 17, 2005·Brain Research. Molecular Brain Research·Claudia A Sumandea, Leslie W-M Fung
Jul 10, 2013·Journal of Medicinal Chemistry·Isaac T SchieferGregory R J Thatcher
Sep 28, 2012·Clinical and Experimental Pharmacology & Physiology·Peng JinJin Tae Hong
Jul 4, 2008·The Journal of Clinical Investigation·Fabrizio TrincheseOttavio Arancio
Jan 19, 2012·Journal of Biomedical Science·Wen-Ching LeeChung-Liang Chien
Sep 8, 2012·Journal of Cell Science·Aidong YuanRalph A Nixon
Aug 23, 2011·PloS One·James B ReineckeMichelle L Steinhilb
Jun 3, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·So-Young Park, Adriana Ferreira
Nov 21, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Mala V RaoRalph A Nixon
Jun 6, 2013·Cellular & Molecular Biology Letters·Arezou GhahghaeiElmira Bahraminejad
Jun 30, 2012·Ageing Research Reviews·Ludovic MartinFaraj Terro
Apr 1, 2014·Scientific Reports·Sheng-Bao SuoRu-Ping Liang
Jan 31, 2017·The Journal of Allergy and Clinical Immunology·Vladislav A LitoshMarc E Rothenberg
Jan 5, 2005·Biochemical and Biophysical Research Communications·Dominic CuerrierPeter L Davies
May 21, 2011·The Journal of Pathology·Ying LiuCheng-Xin Gong
Jun 10, 2005·FEBS Letters·Marta Artal-Sanz, Nektarios Tavernarakis
Sep 9, 2006·CNS Drug Reviews·Antoni CaminsMercè Pallàs
Sep 18, 2008·Journal of Neurochemistry·Balapal S BasavarajappaOttavio Arancio
Jun 4, 2005·Cell Death and Differentiation·F DemarchiC Schneider
Aug 1, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Karni S MoshalSuresh C Tyagi
May 18, 2019·Molecular Neurodegeneration·Alessandro Didonna, Puneet Opal
Dec 17, 2011·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Makoto HiguchiTakaomi C Saido
Mar 9, 2019·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Xingjian Wang, Wei Zheng
Oct 19, 2016·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Shuang ChenKun Xiong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Calcium & Bioenergetics

Bioenergetic processes, including cellular respiration and photosynthesis, concern the transformation of energy by cells. Here is the latest research on the role of calcium in bioenergetics.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.